an assessment of the present and future roles of non-ligand gated ion channel modulators as cns therapeutics

Expert Opinion on Pharmacotherapy

Volumn 1, Issue 1, 1999, Pages 61-70

  Gribkoff, Valentin K ^a   Starrett, John E ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

Anticonvulsants; Calcium channels; Central nervous system; Cognition enhancers; Ion channels; Nenroprotectants; Potassium channels; Sodium channels

Indexed keywords

CENTRAL NERVOUS SYSTEM AGENTS; ION CHANNEL;

AMINO ACID SEQUENCE; ANIMAL; BRAIN DISEASE; CHANNEL GATING; DRUG EFFECT; HUMAN; MOLECULAR GENETICS; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; BRAIN DISEASES; CENTRAL NERVOUS SYSTEM AGENTS; HUMANS; ION CHANNEL GATING; ION CHANNELS; MOLECULAR SEQUENCE DATA;

EID: 0033224554     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.1.1.61     Document Type: Article

References (47)

1. GOLDSTEIN S: A structural vignette common to voltage sensors and conduction pores: canaliculi. Neurone (1996) 16:717-722.
2. WANNER SG, KOCH KO, KOSCHAK A et al.: High-conductance calcium-activated potassium channels in rat brain: pharmacology, distribution, and subunit composition. Biochemistry (1999) 38:5392-5400.
3. MEIR A, GINSBURG S, BUTKEVITCH A et al.-. Ion channels in presynaptic nerve terminals and control of transmitter release. Pbysiol. Rev. (1999) 79:1019-1088.
4. 2+ and synaptic plasticity. Cell Calcnum (1998) 24:377-385.
5. SCHIFFMANN SN, CHERON G, LOHOF A et al.: Impaired motor coordination and Purkinje cell excitability in mice lacking calretinin. Pmc. Natl. Acad. Sci. USA (1999) 96:5257-5262.
6. KRISTIAN T, SIESJO BK: Calcium in ischémie cell death. Stroke (1998) 29:705-718.
7. 2+ channel in rat sympathetic ganglia and brain. Neuron (1997) 18:153-166.
8. MINTZI, ADAMS ME, BEAN BP: P type calcium channels in rat central and peripheral neurons. Keiiron (1992) 9:85-95.
9. RANDALL A, TSIEN R: Contrasting biophysical and pharmacological properties of T type and K type calcium channels. Netiropharmacology (1997) 36:879-893.
10. PEREZ-REYES E, CRIBBS LL, DAUD A et al.: Molecular characterization of a neuronal low voltage activated T type calcium channel. Nature (1998) 391:896-900.
11. DAVILA HM: Molecular and functional diversity of voltage-gated calcium channels. Ann. AT Acacl. Sci. (1999) 868:102-117.
12. GOLDIN AL: Voltage-gated sodium channels. In: Liganclantl Voltage-Gated Ion Channels (Volume 2). North RA (Ed.), CRC Press, Boca Raton, USA (1995):73-112.
13. GOLDIN AL: Diversity of mammalian voltage-gated sodium channels. Ann. W Acacl. Sci. (1999) 868:38-50.
14. JAN LY. JAN YN: Voltage-gated and inwardly rectifying potassium channels.J. Pbysiol. (1997) 505:267-282.
15. DOLLY JO, PARCEJ DN: Molecular properties of voltage-gated K" channels.J. Bioenerg. Biomember. (1996) 28:231-253.
16. GOLDSTEIN S, WANG KW, ILAN N, et al. Sequence and function of the two-P domain potassium channels: Implication of an emerging superfamily. J Mol. Med. (1998) 76:13-20.
17. TAYLOR CP: Voltage-gated channels as targets for anticonvulsant, analgesic and neuroprotective drugs. Curr. I'bann. Design (1996) 2:375-388.
18. RALL TW, SCHLEIFER LS: Drugs effective in the therapy of the epilepsies. In: Tl)c Pharmacological Basis of Wjerapeiitics (Eighth Edition). Gilman AG, Rail TW, Nies AS, Taylor P (Eds.), Pergamon Press, Elsmford, New York, USA (1993):436-462.
19. SEVERT L, COULTER DA, SOMBARTI S et al.: Topiramate selectively blocks kainate currents in cultured hippocampal neurons. Epilepsia (1995) 36(Suppl. 4):38.
20. WHITE HS, BRWON SD, SKEEN GA et al.: The Investigational anticonvulsant topiramatc potentiates GABA-evoked currents in mouse cortical neurons. Epilepsia (1995) 36(Suppl. 4):34.
21. PISANI A, STEFANI A, SINICHALCHI A et al.: Electrophysiological actions of fclbamatc on rat striatal neurones. Br.J. Pbarmacol. (1995) 116(3):2053-206l.
22. SUBRAiMANIAM S, RHOJ M, PENIX L et al: Felbamate block of the N-methyl-D-aspartate receptor. J Pharmacol. Exf>. Tljcr. (1995) 273:878-886.
23. KELLY KM, GROSS RA, MACDONALD R: Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neurons. Neurosci Letts. (1990) 116:233-238
24. CHEUNG H, KAMP D, HARRIS E: AnJH vitro investigation of the action of lamotrigine on neuronal voltageactivated sodium channels. Epilepsy Res. (1992) 13:107-112.
25. LEES G, LEACH MJ: Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary ncuroglial cultures from rat cortex. Brain Res. (1993) 612:190-199.
26. SCHAUF CL: Zonisamidc enhances slow sodium inactivation in Myxicota. Brain Res. (1987) 413:185-189
27. SUZUKI S, KANVAKAMI K, NISHIMURA S et al.: Zonisamide blocks T-typc calcium channel in cultured neurons of rat cerebral cortex. Epilepsy Res. (1992) 12:21-27.
28. + channels. Eur.J. Pbarmacol. (1996) 3l4(lJ2):69-73.
29. KISS B, KARPATI E: The mechanism of action of vinpocetine. Ada Pbann. Hung. (1996) 66(5):213-224.
30. COULTER DA, HUGUENARD JR, PRINCE DA: Characterization of cthosuximidc reduction of low-threshold calcium current in thalamic neurons. Ann. Neurol. (1989) 25:582-593.
31. COULTER DA, HUGUENARD JR, PRINCE DA: Differential effects of petit mal anticonvulsants and convulsants on thalamic neurones: GABA current blockade. (1990) 100:807-813.
32. FOX JA: Irreversible and reversible blockade of LVIR32 calcium channel currents by synthetic MVIIA and iodinated MVIIC to-conopeptides. Pflug Arch. Eur. J. PJjysiol. (1995) 429(6):873-875.
33. MARVC'iCK C: Nature's agents help heal humans- some now take steps to reciprocate: complex cone snail venom. JAMA (1998) 279(21): 1678-1679.
34. MCGUIRE D, BOWERBOX S, FELLMAN JD et al.: Sympatholysis after neuron-specific, N-type, voltagesensitive calcium channel blockade: first demonstration of N-channel function in humans. J. Cardioi-as. Pbarmacol. (1997) 30(3):400-403.
35. DIENNER H, KAUBE H, LIMMROTH V: A practical guide to the management and prevention of migraine. Drugs (1998) 56:811-824.
36. EDWARDS KR, GOODMAN WA. NORTON JA et al.: Intravenous Valproatc (Dcpacon) for acute treatment of migraine headache. 41st Animal Meeting of the American Association for the Study of Headache. Boston, USA (1999). Abstract 201.
37. BARCHI RL: Ion channel mutations affecting muscle and brain. Cnir. Opin. Xeurol. (1998) 11:461-468.
38. DENVER J cl al.: HTS approaches to voltage-gated ion channel drug discovery. Drug Discor. Today (1998) 3:323-332.
39. STAHRETT JE, JR., DWORETZKY SI, GKIISKOFF VK: Modulators of large-conductance calcium-activated potassium (BK) channels as potential therapeutic targets. Ciirr. I'barm. Design (1996) 2:413-428.
40. WANG Q, BOXXTES NE, TOXX'BIN JA: The molecular basis of long QT syndrome and prospects for therapy. Mol. Mecl. Today (1998) 4:382-388.
41. SINGH NA, CHARLIER C, STAUFFER D et al.: A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Kature Genetics (1998) 18:25-29.
42. BIEVERT C et al.: A potassium channel mutation in neonatal human epilepsy. Science (1998) 279:403-406.
43. KRALL WJ, SRAMEK JJ, CUTLER NR: Cholinesterase inhibitors: a therapeutic strategy for Alzheimer's disease. Ann. Pbarmacother. (1999) 33:441-450
44. EID CN. ROSE GM: Cognition enhancement strategics by ion channel modulation of ncurotrans miss ion. Curr. Pbcirm. De-sign (1999) 5:345-361.
45. WANG HS, PAN Z, SHI W et al.: KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channeL Science (1998) 282:1890-1893.
46. DOBLE A. The role of excitotoxicity in neurodcgcncrativc disease: implications for therapy. Pbannacol. Tber. (1999)81:163-221.
47. YU SP, YEH C, GOTTKON F et al.: Role of the outward delayed rectifier K' current in ccramidc-induccd caspasc activation and apoptosis in cultured cortical neurons.J Neunxbem. (1999) 73:933-941.